| Ms Jeanne Civiello, | |
|
66 Suzanne Dr, Portsmouth, NH 03801-5956 | |
| (978) 337-4894 | |
| Not Available |
| Full Name | Ms Jeanne Civiello |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 66 Suzanne Dr, Portsmouth, New Hampshire |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1740922889 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 1079 (New Hampshire) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Jeanne Civiello, 66 Suzanne Dr, Portsmouth, NH 03801-5956 Ph: (978) 337-4894 | Ms Jeanne Civiello, 66 Suzanne Dr, Portsmouth, NH 03801-5956 Ph: (978) 337-4894 |
News Archive
A new biologic medication - the first for HIV - is showing promise in treating patients with multidrug resistance, according to phase 3 research being presented at IDWeek 2016.
Fifty-nine percent of U.S. businesses in 2009 intend to increase employees' deductibles, copayments or out-of-pocket spending limits, according to preliminary data of a national survey released on Thursday by Mercer, the AP/Houston Chronicle reports.
Endotis Pharma, a world leader in the development of neutralizable anticoagulants, today announced enrolment of the first patients into a Phase IIa study using EP217609 and its specific antidote avidin to manage coagulation during open-heart surgery.
Helicos BioSciences Corporation announced today that, as part of the Company's previously disclosed efforts to consider alternatives to its existing long-term strategy, it is in the process of implementing a strategic shift to focus the business on the diagnostics markets. In connection with this effort, the Company has committed to a consolidation and reorganization of its operations in order to reduce operating costs.
Biodel Inc. announced today the award of two research grants by the Juvenile Diabetes Research Foundation to Stanford University and Oregon Health & Science University to evaluate the use of VIAject (ultra-rapid-acting injectable human insulin) in the treatment of diabetes.
› Verified 7 days ago
Abbie Frank, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 50 Clough Drive, Portsmouth, NH 03801 Phone: 603-436-1708 | |
Morgan James, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 50 Clough Dr, Portsmouth, NH 03801 Phone: 603-436-1708 | |
Jenna Cafora, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 7 Greenleaf Woods Dr Unit 201, Portsmouth, NH 03801 Phone: 207-590-9194 | |
Suzanne Danforth, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 197 Madison St, #2, Portsmouth, NH 03801 Phone: 603-674-4026 | |
Kaila Cote, MS, CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 105 Corporate Dr, Portsmouth, NH 03801 Phone: 603-893-2900 | |
The Language And Learning Connection Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1 New Hampshire Ave, Suite 125, Portsmouth, NH 03801 Phone: 603-766-4955 Fax: 603-766-1999 | |
Lara Jean Coughlin, MS,CCC-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 7 Greenleaf Woods Dr, Portsmouth, NH 03801 Phone: 603-205-5792 |